PLA2G7 Antilichaam

The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency.

7941

Q13093

Q13093

Human

This PLA2G7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-228 amino acids from the Central region of human PLA2G7.

Unconjugated

Primary Antibodies

Immunology

This antibody is purified through a protein A column, followed by peptide affinity purification.

Batch dependent

Supplied in PBS with 0.09% (W/V) sodium azide.

None

Blue Ice

Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

50 kDa

Rabbit Ig

PLA2G7

Platelet-activating factor acetylhydrolase

Homo sapiens

Fan, P., et al. Hum. Reprod. 25 (5) :1288-1294 (2010)

Paik, J.K., et al. Clin. Chim. Acta 411 (7-8), 486-493 (2010)

Meng, X., et al. Psychiatry Res 175 (1-2), 186-187 (2010)

McGeachie, M., et al. Circulation 120 (24) :2448-2454 (2009)

Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, 1-alkyl-2-acetylglycerophosphocholine esterase, 2-acetyl-1-alkylglycerophosphocholine esterase, Group-VIIA phospholipase A2, gVIIA-PLA2, LDL-associated phospholipase A2, LDL-PLA (2), PAF 2-acylhydrolase, PLA2G7, PAFAH

WB, IHC-P, Flow

2497687

Liquid